drugset / Trial / NCT02824393

Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria

NCT02824393 ↗

Non-randomizedFactorialOpen-labelTreatment

Summary

The aim of this study is to determine whether autologous adipose tissue derived Mesenchymal Stem Cells of treatment for chronic autoimmune urticaria is safe and effective.

Timeline

Start
2017-03-03
Primary completion
2018-05-15
Completion
2018-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous mesenchymal stem cell Unknown 1e+06 cells/kg Intravenous

Indications